Veru Shares Pop on Novo Wegovy Tie-Up, Uncertainty Lingers Over Key Clause

Veru Inc. shares stayed active premarket Friday as the biotech said it has a supply deal with Novo Nordisk tied to a weight-loss study using Wegovy. Benzinga data had the stock at $3.70 before the open at 7:01 a.m. ET. The move followed Thursday’s rally, when it closed at $4.23, up 88% for the day.

5 June 2026

Veru shares jump after Novo Nordisk deal draws traders

Veru Inc. shares jumped over 100% Thursday. The small-cap biotech said it's got a clinical supply deal with Novo Nordisk for its obesity trial. That puts a major drugmaker next to one of the more speculative weight-loss names in the market.

4 June 2026

NASDAQ:VERU·NYSE:NVO·Stock Market

Veru shares jump after Novo Nordisk deal draws traders

TechStock² Updates

American Airlines Shares Edge Down 0.6% Despite Record Revenue, Yielding 0.4% Net Margin

IREN Shares Slide 12.5% as $30 Billion Capex Faces $4 Billion AI Revenue Pace

Disney Stock Rises 1.2% as Pokémon Deal Targets a $4.7 Billion Streaming Base

CME Group Shares Gain 1.7% as Record Trading Volume Lifts Margin to 69.5%

Lululemon Shares Rise 5.1% Despite Earnings Highlighting 410-Basis-Point Margin Decline

Chevron Shares Gain 1.1%, Market Cap Grows by $4.1 Billion as Venezuela Deal Approaches

SoFi Shares Slide 5.8% Despite 43% Revenue Gain as Sales Multiple Hits 4.9x

Plug Power Shares Drop 3.5% After Quarterly Cash Outflow Reduces $162 Million Reserve

Amazon Stock Jumps 4%, Adding $110 Billion as AI Spending Turns Free Cash Flow Negative

Ondas Shares Drop 9.7% After Reporting Thirteenfold Revenue Jump Amid $50.6 Million EBITDA Loss

Investment Disclaimer